Search research articles
Contact Us
Filters
Showing results (61-70 of 181) with videos related to
Page
of 19
Sort By:
Cancer
|
March 18, 2014
Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: a pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab
Shubham Pant, Ludmila K Martin, Susan Geyer, et al.
BMC Cancer
|
January 4, 2022
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
Julia E Douglas, Suyu Liu, Junsheng Ma, et al.
Cancer Investigation
|
October 14, 2015
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors
Johanna C Bendell, Suzanne F Jones, Lowell Hart, et al.
Cancer
|
November 21, 2014
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors
Johanna C Bendell, Manish R Patel, Jeffrey R Infante, et al.
Journal of Gastrointestinal Oncology
|
November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imaging
Jane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2018
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
Johanna C Bendell, Anna M Varghese, David M Hyman, et al.
The Oncologist
|
June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2023
Adagrasib in Advanced Solid Tumors Harboring a <i>KRAS</i><sup></sup> Mutation
Tanios S Bekaii-Saab, Rona Yaeger, Alexander I Spira, et al.
Journal of Gastrointestinal Cancer
|
April 29, 2023
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials
Rishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, et al.
Journal of Gastrointestinal Cancer
|
January 18, 2025
Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma
Enoch Chang, Alexander D Sherry, Jakob Liermann, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 181) with videos related to
Sort By:
Page
of 19
Cancer
|
March 18, 2014
Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: a pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab
Shubham Pant, Ludmila K Martin, Susan Geyer, et al.
BMC Cancer
|
January 4, 2022
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
Julia E Douglas, Suyu Liu, Junsheng Ma, et al.
Cancer Investigation
|
October 14, 2015
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors
Johanna C Bendell, Suzanne F Jones, Lowell Hart, et al.
Cancer
|
November 21, 2014
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors
Johanna C Bendell, Manish R Patel, Jeffrey R Infante, et al.
Journal of Gastrointestinal Oncology
|
November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imaging
Jane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2018
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
Johanna C Bendell, Anna M Varghese, David M Hyman, et al.
The Oncologist
|
June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2023
Adagrasib in Advanced Solid Tumors Harboring a <i>KRAS</i><sup></sup> Mutation
Tanios S Bekaii-Saab, Rona Yaeger, Alexander I Spira, et al.
Journal of Gastrointestinal Cancer
|
April 29, 2023
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials
Rishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, et al.
Journal of Gastrointestinal Cancer
|
January 18, 2025
Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma
Enoch Chang, Alexander D Sherry, Jakob Liermann, et al.
Page
of 19